21 February 2017
Biobased Glucaric Acid
Intermediate for Rennovia’s biobased adipic acid
A world scale biobased adipic acid plant
will consume about 500 million pounds per year of glucaric acid
Additional addressable global market for glucaric acid
predicted to be over $500 million per year
DETAILS
Johnson Matthey and Rennovia Inc.,
a privately held company
that develops novel catalysts and processes
for the cost advantaged production of chemical products
from renewable feedstocks,
announced today that they have signed
a license agreement with
Archer Daniels Midland Company (NYSE: ADM)
to provide catalyst and process technology
for catalytic production of
bio-based glucaric acid.
The licensed process, jointly developed
between Johnson Matthey and Rennovia,
combines the efficiency and selectivity
of heterogeneous catalytic process technology
with the use of renewable feedstocks
to produce bio-based glucaric acid.
Glucaric acid is an emerging platform chemical
which has a wide range of applications in
* detergents and cleaners,
* concrete formulations,
* de-icing and anti-corrosion markets.
Kevin Moore,
President of Renewable Chemicals for ADM
“ADM continues to work toward commercialization
of glucaric acid as a higher value product within
our portfolio of bio-based performance chemicals,”
“We see a strong synergy in leveraging
Rennovia’s breakthrough catalyst technology
along with the process scale-up capabilities
of Johnson Matthey to shorten the time frame
needed to bring this new product
to market for our customers.”
David Prest,
Director of Business Development
for Johnson Matthey’s Process Technologies Division
“We are proud to announce the licensing
of this new and innovative technology to ADM,
and we are excited about the future of this technology,
which draws upon the fundamental process
and catalyst development expertise
within Johnson Matthey.
This achievement also demonstrates
the value of a strong collaborative approach,
working together with Rennovia
to commercialize a process for biobased chemicals.”
Robert Wedinger,
President and CEO of Rennovia
“We are delighted that ADM has decided to license
glucaric acid technology
from Rennovia and Johnson Matthey,”
“It demonstrates the commitment of an industry leader
and a key partner of Rennovia. We look forward to
working even closer together
to commercialize our innovative process
for the production of cost advantaged glucaric acid.”
Contact:
Jackie Anderson
ADM Media Relations
media@adm.com 312-634-8484
Contact:
Jeanette Simpson
Johnson Matthey Business Manager
Tel: +44 (0) 01763 253000
Email: jeanette.simpson@matthey.com
Contact:
Rennovia Inc.
3040 Oakmead Village Drive Santa Clara,
California 95051 USA
Main Phone: (+1) (408) 855 6450
www.rennovia.com
info@rennovia.com
WWW.CHEMWINFO.COM BY KHUN PHICHAI
